Overview

Efficacy of Intralesional PRP in Treatment of Onychomycosis

Status:
Not yet recruiting

Trial end date:
2022-09-01

Target enrollment:
0

Participant gender:
All

Summary

This study aims to investigate efficacy of intralesional PRP in treatment of finer nail onychomycosis.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Sohag University

Treatments:

Terbinafine

Criteria

Inclusion Criteria:

- Eligible participants will be adult patients (> 18 years) with onychomycosis confirmed
by dermoscopy, direct KOH microscopic examination and positive culture..

Exclusion Criteria:

- Patients with one or more with the following criteria will be excluded.

1. Pregnant and lactating women.

2. Patients received topical and/or systemic antifungal therapy during the previous
3 months.

3. Patients with impaired liver or renal functions.

4. Patients with anemia (hemoglobin level <10mg/dl), thrombocytopenia (platelet
count < 100,000 /µL), coagulopathies or patients on anticoagulant therapy as
aspirin and patients with iron deficiency.